Clinical trial Recruiting at 1 site Observational Ages 3 to 25

Collecting movement data from healthy children

Official title: Pediatric Normative Markerless Movement Analysis Data Collection Project

Run by MultiCare Health System Research Institute · NCT06249880 · Data updated 2026-11-12

This study is collecting movement data from healthy children aged 3 to 25 to help understand how kids with leukemia move compared to their peers.

Quick facts

Study typeObservational
Ages3 Years to 25 Years
SexAll
Enrollment40 (estimated)
SponsorMultiCare Health System Research Institute
Academic / other
Locations1 site (Puyallup, Washington)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedMarch 9, 2026
Trial IDNCT06249880 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are typically developing children aged 3 to 25 years who can walk independently.

Probably not a fit

Patients with neuromuscular disorders or developmental delays will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to gather baseline movement data from a normative population of children aged 3 to 25 years, matching the demographics of pediatric patients expected to be treated at the Mary Bridge Children's Research & Movement Lab. The study will recruit 20 male and 20 female typically developing individuals and will utilize non-invasive motion analysis and force plate data to assess their bipedal gait patterns. The collected data will serve as a reference for understanding movement in children with pediatric acute lymphoblastic leukemia (ALL).

Why it matters

Potential benefit: If successful, this study could provide valuable normative data to improve the assessment and treatment of movement disorders in pediatric ALL patients.

How similar studies have gone: While similar studies have been conducted, this specific approach of collecting normative data for pediatric ALL patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion).
* Ambulate independently and without the use of assistive devices or orthoses.
* Willing and interested in participating.

Exclusion Criteria:

* Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues.
* Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity.
* Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment.
* History of premature birth.
* Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.

Where it's running

  • Mary Bridge Children's Therapy Unit - Research & Movement Lab
    Puyallup, Washington, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.